ArticlePloS one2026
Plasma neurofilament light chain in type 2 diabetes: Associations with diabetic peripheral neuropathy, age, and renal function in a pilot cross-sectional study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetic peripheral neuropathy (DPN) is a common complication of type 2 diabetes mellitus (T2DM). Neurofilament light chain (NfL) is a circulating marker of neuroaxonal injury, but its interpretation may be influenced by age and renal function.
objectiveTo evaluate the association between plasma NfL concentrations and DPN in T2DM while accounting for age and renal function.
methodsThis pilot cross-sectional study included 41 patients with T2DM, of whom 20 had DPN diagnosed by a neurologist based on clinical and electrophysiological assessment and 21 had no DPN. Plasma NfL concentrations were measured using single-molecule array technology. Group differences and associations with clinical variables were assessed using non-parametric methods. Sequential linear regression models using natural log-transformed NfL evaluated the association of DPN status with NfL before and after adjustment for age and estimated glomerular filtration rate (eGFR).
resultsPlasma NfL concentrations were higher in patients with DPN than in those without DPN (median 12.96 vs 8.29 pg/mL, p = 0.035). In sequential regression analysis, DPN status was associated with higher ln-transformed NfL in the unadjusted model (B = 0.499, 95% CI 0.108-0.890; p = 0.014), but the association was attenuated after adjustment for age and eGFR (B = 0.241, 95% CI -0.040-0.522; p = 0.091). In the fully adjusted model, age and eGFR remained associated with ln(NfL), and the model explained 62.0% of its variance.
conclusionsPlasma NfL concentrations were higher in patients with DPN in unadjusted analyses, but the association was attenuated after accounting for age and renal function. These exploratory findings highlight the importance of considering age and renal function when interpreting circulating NfL concentrations in T2DM and require confirmation in larger prospective cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.